These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21543855)

  • 1. Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086).
    Cendron L; Veggi D; Girardi E; Zanotti G
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 May; 67(Pt 5):531-5. PubMed ID: 21543855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of the factor H-binding protein, a survival factor and protective antigen of Neisseria meningitidis.
    Cantini F; Veggi D; Dragonetti S; Savino S; Scarselli M; Romagnoli G; Pizza M; Banci L; Rappuoli R
    J Biol Chem; 2009 Apr; 284(14):9022-6. PubMed ID: 19196709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.
    Tzeng YL; Giuntini S; Berman Z; Sannigrahi S; Granoff DM; Stephens DS
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32958529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neisseria meningitidis factor H-binding protein bound to monoclonal antibody JAR5: implications for antibody synergy.
    Malito E; Lo Surdo P; Veggi D; Santini L; Stefek H; Brunelli B; Luzzi E; Bottomley MJ; Beernink PT; Scarselli M
    Biochem J; 2016 Dec; 473(24):4699-4713. PubMed ID: 27784765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modular architecture of meningococcal factor H-binding protein.
    Beernink PT; Granoff DM
    Microbiology (Reading); 2009 Sep; 155(Pt 9):2873-2883. PubMed ID: 19574307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
    Rossi R; Konar M; Beernink PT
    Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.
    Bianchi F; Veggi D; Santini L; Buricchi F; Bartolini E; Lo Surdo P; Martinelli M; Finco O; Masignani V; Bottomley MJ; Maione D; Cozzi R
    FASEB J; 2019 Nov; 33(11):12099-12111. PubMed ID: 31442074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting oriented with antibodies.
    Klontz EH; Sundberg EJ
    Biochem J; 2017 Feb; 474(4):517-519. PubMed ID: 28159897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the OmpA-like domain of RmpM from Neisseria meningitidis.
    Grizot S; Buchanan SK
    Mol Microbiol; 2004 Feb; 51(4):1027-37. PubMed ID: 14763978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR dynamics and antibody recognition of the meningococcal lipidated outer membrane protein LP2086 in micellar solution.
    Mascioni A; Moy FJ; McNeil LK; Murphy E; Bentley BE; Camarda R; Dilts DA; Fink PS; Gusarova V; Hoiseth SK; Malakian K; Mininni T; Novikova E; Lin S; Sigethy S; Zlotnick GW; Tsao DH
    Biochim Biophys Acta; 2010 Feb; 1798(2):87-93. PubMed ID: 19835839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.
    McNeil LK; Zagursky RJ; Lin SL; Murphy E; Zlotnick GW; Hoiseth SK; Jansen KU; Anderson AS
    Microbiol Mol Biol Rev; 2013 Jun; 77(2):234-52. PubMed ID: 23699256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.
    Konar M; Pajon R; Beernink PT
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14823-8. PubMed ID: 26627237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.
    Schneider MC; Prosser BE; Caesar JJ; Kugelberg E; Li S; Zhang Q; Quoraishi S; Lovett JE; Deane JE; Sim RB; Roversi P; Johnson S; Tang CM; Lea SM
    Nature; 2009 Apr; 458(7240):890-3. PubMed ID: 19225461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
    Findlow J; Bayliss CD; Beernink PT; Borrow R; Liberator P; Balmer P
    Vaccine; 2020 Nov; 38(49):7716-7727. PubMed ID: 32878710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of outer membrane protein NMB0315 from Neisseria meningitidis.
    Wang X; Yang X; Yang C; Wu Z; Xu H; Shen Y
    PLoS One; 2011; 6(10):e26845. PubMed ID: 22046377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).
    Gandhi A; Balmer P; York LJ
    Postgrad Med; 2016 Aug; 128(6):548-56. PubMed ID: 27467048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.
    Shaughnessy J; Lewis LA; Jarva H; Ram S
    Infect Immun; 2009 May; 77(5):2094-103. PubMed ID: 19273554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccines.
    Beernink PT; Shaughnessy J; Stefek H; Ram S; Granoff DM
    Clin Vaccine Immunol; 2014 Nov; 21(11):1505-11. PubMed ID: 25185576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.
    Scarselli M; Cantini F; Santini L; Veggi D; Dragonetti S; Donati C; Savino S; Giuliani MM; Comanducci M; Di Marcello F; Romagnoli G; Pizza M; Banci L; Rappuoli R
    J Mol Biol; 2009 Feb; 386(1):97-108. PubMed ID: 19100746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.
    Beernink PT; LoPasso C; Angiolillo A; Felici F; Granoff D
    Mol Immunol; 2009 May; 46(8-9):1647-53. PubMed ID: 19286260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.